Left ventricular assist device-related infections: a multicentric study - Archive ouverte HAL Access content directly
Journal Articles Clinical Microbiology and Infection Year : 2017

Left ventricular assist device-related infections: a multicentric study


Objectives: The implantable left ventricular assist device (LVAD) is a major therapeutic development for end-stage heart failure in selected patients. As their use is expanding, infectious complications are emerging, with limited data available to guide their management. We aimed to better characterize LVAD-related infections.Methods: We enrolled all consecutive patients diagnosed with LVAD-related infections in three referral centres in France, using a standardized definition of infections in patients with LVAD. Data were collected from medical charts using a standardized questionnaire.Results: Between 2007 and 2012, 159 patients received LVAD for end-stage heart failure. Among them, 36 (22.6%; 5 women, 31 men) presented at least one infectious complication, after a median time of 2.9 months from LVAD implantation (interquartile range, 1.8-7.5), with a median follow up of 12 months (interquartile range 8-17). Main co-morbidities were alcoholism (33%), diabetes (11%) and immunosuppression (11%). Mean age at implantation was 51 (+/- 11) years. LVAD were implanted as bridge-to-transplantation (n=22), bridge-to-recovery (n=8), destination therapy (n=4), or unspecified (n=2). LVAD-related infections were restricted to the driveline exit site (n=17), had loco-regional extension (n=13), or reached the internal pump (n=3). The main bacteria isolated were Staphylococcus aureus (n=20), coagulase-negative staphylococci (n=7), Enterobacteriaceae (n=14), Pseudomonas aeruginosa (n=10) and Corynebacterium sp. (n=7), with polymicrobial infections in 19 cases. LVAD could be retained in all patients, with the use of prolonged antibacterial treatment in 34 (94%), and debridement in 17 (47%). One patient died due to LVAD-associated infection.Conclusions: LVAD-related infections are common after LVAD implantation, and may be controlled by prolonged antibiotic treatment. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Fichier principal
Vignette du fichier
Simeon - Left ventricular assist device-related infections-accepted.pdf (118.3 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-01619296 , version 1 (07-06-2018)



S. Simeon, E. Flecher, M. Revest, M. Niculescu, J. -C. Roussel, et al.. Left ventricular assist device-related infections: a multicentric study. Clinical Microbiology and Infection, 2017, 23 (10), pp.748-751. ⟨10.1016/j.cmi.2017.03.008⟩. ⟨hal-01619296⟩
139 View
218 Download



Gmail Facebook Twitter LinkedIn More